catalyst

Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle ( — primary completion

as of 2026-07-01
Monitor thisAsk about this
at a glance
2018-12-17 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.

Event

What
Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle ( — primary completion
Type
Trial Readout
Date
2018-12-17
Date type
ACTUAL
Phase
Phase 3
This event happened.
relationships
The graph out of here
trial
Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle (ISM)® in Patients With Acute Schizophrenia
trial